BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35550245)

  • 1. Cardiac sarcoidosis outcome differences: A comparison of patients with de novo cardiac versus known extracardiac sarcoidosis at presentation.
    Rosen NS; Pavlovic N; Duvall C; Wand AL; Griffin JM; Okada DR; Chrispin J; Tandri H; Mathai SC; Stern B; Pardo CA; Kasper EK; Sharp M; Chen ES; Gilotra NA
    Respir Med; 2022 Jul; 198():106864. PubMed ID: 35550245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes and Predictors of Long-Term Survival in Patients With and Without Previously Known Extracardiac Sarcoidosis Using Machine Learning: A Swedish Multicenter Study.
    Bobbio E; Eldhagen P; Polte CL; Hjalmarsson C; Karason K; Rawshani A; Darlington P; Kullberg S; Sörensson P; Bergh N; Bollano E
    J Am Heart Assoc; 2023 Aug; 12(15):e029481. PubMed ID: 37489729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres.
    Fussner LA; Karlstedt E; Hodge DO; Fine NM; Kalra S; Carmona EM; Utz JP; Isaac DL; Cooper LT
    Eur J Heart Fail; 2018 Dec; 20(12):1713-1720. PubMed ID: 30378224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes of Cardiac Sarcoid: Prognostic Implications of Isolated Cardiac Involvement and Impact of Diagnostic Delays.
    Sink J; Joyce C; Liebo MJ; Wilber DJ
    J Am Heart Assoc; 2023 Oct; 12(19):e028342. PubMed ID: 37750587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Adverse Cardiovascular Events in Cardiac Sarcoidosis Independent of Left Ventricular Function.
    Rosenthal DG; Cheng RK; Petek BJ; Masri SC; Mikacenic C; Raghu G; Patton KK
    Am J Cardiol; 2020 Jul; 127():142-148. PubMed ID: 32402485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex and Race Differences in Cardiac Sarcoidosis Presentation, Treatment and Outcomes.
    Duvall C; Pavlovic N; Rosen NS; Wand AL; Griffin JM; Okada DR; Tandri H; Kasper EK; Sharp M; Chen ES; Chrispin J; Gilotra NA
    J Card Fail; 2023 Aug; 29(8):1135-1145. PubMed ID: 37062472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias.
    Crawford T; Mueller G; Sarsam S; Prasitdumrong H; Chaiyen N; Gu X; Schuller J; Kron J; Nour KA; Cheng A; Ji SY; Feinstein S; Gupta S; Ilg K; Sinno M; Abu-Hashish S; Al-Mallah M; Sauer WH; Ellenbogen K; Morady F; Bogun F
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1109-15. PubMed ID: 25266311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis.
    Padala SK; Peaslee S; Sidhu MS; Steckman DA; Judson MA
    Int J Cardiol; 2017 Jan; 227():565-570. PubMed ID: 27836297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function.
    Zipse MM; Tzou WS; Schuller JL; Aleong RG; Varosy PD; Tompkins C; Borne RT; Tumolo AZ; Sandhu A; Kim D; Freeman AM; Weinberger HD; Maier LA; Sung RK; Nguyen DT; Sauer WH
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1939-1948. PubMed ID: 31257683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular Arrhythmias in Cardiac Sarcoidosis.
    Okada DR; Smith J; Derakhshan A; Gowani Z; Misra S; Berger RD; Calkins H; Tandri H; Chrispin J
    Circulation; 2018 Sep; 138(12):1253-1264. PubMed ID: 30354431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of electrophysiologic testing for sudden death risk stratification in cardiac sarcoidosis patients with mildly impaired left ventricular function.
    Tandon P; Mosleh T; Mustafa A; Miodownik H; Miller M; Morgenthau AS
    Respir Med; 2022 Jan; 191():106712. PubMed ID: 34906899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of outcome in a contemporary cardiac sarcoidosis population: Role of brain natriuretic peptide, left ventricular function and myocardial inflammation.
    Kouranos V; Khattar RS; Okafor J; Ahmed R; Azzu A; Baksi JA; Wechalekar K; Cowie MR; Wells AU; Lüscher TF; Sharma R
    Eur J Heart Fail; 2023 Dec; 25(12):2287-2298. PubMed ID: 37877328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis.
    Siontis KC; Santangeli P; Muser D; Marchlinski FE; Zeppenfeld K; Hoogendoorn JC; Narasimhan C; Sauer WH; Zipse MM; Kapa S; Vedantham V; Rosenthal DG; Robinson MR; Patton KK; Murgatroyd F; Chicos AB; Soejima K; Roukoz H; Sacher F; Bhan A; Appelbaum J; Dickfeld T; Mankad P; Ellenbogen KA; Kron J; Kim HM; Froehlich J; Eagle KA; Bogun FM; Crawford TC
    JAMA Cardiol; 2022 Feb; 7(2):175-183. PubMed ID: 34787643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE-CS study.
    Maeda D; Matsue Y; Dotare T; Sunayama T; Iso T; Yoshioka K; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Tanaka H; Okumura T; Baba Y; Minamino T
    Eur J Heart Fail; 2024 Jan; 26(1):77-86. PubMed ID: 37823255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis.
    Shafee MA; Fukuda K; Wakayama Y; Nakano M; Kondo M; Hasebe Y; Kawana A; Shimokawa H
    J Cardiol; 2012 Dec; 60(6):448-53. PubMed ID: 22944174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcome in Probable Versus Absolute Cardiac Sarcoidosis.
    Simonen P; Lehtonen J; Kupari M
    Am J Cardiol; 2019 Feb; 123(4):674-678. PubMed ID: 30527771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive Hemodynamics and Rejection Rates in Patients With Cardiac Sarcoidosis After Heart Transplantation.
    Rosenthal DG; Anderson ME; Petek BJ; Arnett DM; Bravo PE; Raghu G; Goldberger ZD; Patton KK; Cheng RK
    Can J Cardiol; 2018 Aug; 34(8):978-982. PubMed ID: 30049365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal left ventricular ejection fraction in risk stratification of patients with cardiac sarcoidosis.
    Hutt E; Brizneda MV; Goldar G; Aguilera J; Wang TKM; Taimeh Z; Culver D; Callahan T; Tang WHW; Cremer PC; Jaber WA; Ribeiro Neto ML; Jellis CL
    Europace; 2023 Aug; 25(9):. PubMed ID: 37721485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac sarcoidosis - an expert review for the chest physician.
    Ho JSY; Chilvers ER; Thillai M
    Expert Rev Respir Med; 2019 Jun; 13(6):507-520. PubMed ID: 30099918
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcome of cardiac sarcoidosis after radiofrequency ablation and placement of AICD- A propensity matched analysis.
    Bandyopadhyay D; Sahoo D; Zein J; Brunken RC; Tchou PJ; Culver DA
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):70-9. PubMed ID: 26237358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.